Showing results (221-230 of 297) with videos related to
Sort By:
Pageof 30
Translational Lung Cancer Research|January 25, 2021
Survival benefit and toxicity profile of adjuvant icotinib for patients with EGFR mutation-positive non-small cell lung carcinoma: a retrospective studyZiqing Zeng, Bo Yan, Yulong Chen, et al.Frontiers in Immunology|June 23, 2022
m6A-Regulator Expression Signatures Identify a Subset of Follicular Lymphoma Harboring an Exhausted Tumor MicroenvironmentTingting Zhang, Hengqi Liu, Fenghua Gao, et al.Blood|May 22, 2016
A clinically relevant in vivo zebrafish model of human multiple myeloma to study preclinical therapeutic efficacyJianhong Lin, Weihong Zhang, Jian-Jun Zhao, et al.Frontiers in Oncology|October 3, 2022
Clinical features and outcomes of patients with follicular lymphoma: A real-world study of 926 patients in ChinaFenghua Gao, Tingting Zhang, Xia Liu, et al.NPJ Precision Oncology|May 25, 2023
PD-1 blockade potentiates neoadjuvant chemotherapy in NSCLC via increasing CD127+ and KLRG1+ CD8 T cellsZhenzhen Hui, Yulin Ren, Dong Zhang, et al.Molecular and Cellular Biology|April 5, 2012
Nuclear translocation of type I transforming growth factor β receptor confers a novel function in RNA processingManasa Chandra, Shengbing Zang, Haiqing Li, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 4, 2018
Chemotherapy Induces Breast Cancer Stemness in Association with Dysregulated MonocytosisLiang Liu, Lin Yang, Wei Yan, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|May 15, 2013
A phase II, randomized, double-blind, placebo-controlled multicenter trial of Endostar in patients with metastatic melanomaChuanliang Cui, Lili Mao, Zhihong Chi, et al.Journal of Experimental & Clinical Cancer Research : CR|July 11, 2026
Mesenchymal stem cell-induced metabolic reprogramming of EGFR-wild-type tumor cells drives therapeutic resistance in EGFR-mutant non-small cell lung cancerHongyu Bie, Jiarui Li, Jialin Liu, et al.Cell Death & Disease|May 6, 2022
CD4+ T cells are required to improve the efficacy of CIK therapy in non-small cell lung cancerShaochuan Liu, Yuan Meng, Liang Liu, et al.Pageof 30